TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07107126: Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

Sponsor: Remedy Plan, Inc. · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 24 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$6,597,360

Rescue Site Savings

+$4,366,824

Unlock Full NCT07107126 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07107126 Rescue Dossier →